InterLymph is governed through investigator-led leadership structures that provide scientific direction, operational oversight, and stewardship of collaborative research activities. Leadership and governance bodies guide consortium priorities, facilitate coordination across studies, and ensure adherence to established policies for data sharing, authorship, and conduct.

Coordinating Committee

The Coordinating Committee oversees day-to-day scientific and operational activities of the consortium, including coordination across working groups, meeting planning, and implementation of governance policies. The Coordinating Committee has a rotating membership and currently includes the members listed below:

• Brenda Birmann, ScD
  Associate Epidemiologist | Assistant Professor of Medicine
  Brigham and Women’s Hospital and Harvard Medical School
• Federico Canzian, PhD
  Group Leader
  German Cancer Research Center (DKFZ)
• Vijai Joseph, PhD
  Associate Attending Geneticist
  Memorial Sloan Kettering Cancer Center
• Rao L. Divi, PhD
  Epidemiology and Genomics Research Program
  Division of Cancer Control and Population Sciences,
  National Cancer Institute

Last Updated: 26 Mar, 2026

Working Group Oversight

Scientific activities within InterLymph are organized through working groups, each led by one or more chairs. Working group activities are conducted under guidance from the Coordinating Committee.

Data Coordinating Centre

Data and administrative coordination for InterLymph is provided by a designated Data Coordinating Centre, which supports communication, data management, and analytic activities across participating studies.